US Patent Issued to Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM), Ecole Nationale Superieure des Mines de Paris on Oct. 6 for "Prediction of BRCAness/homologous recombination deficiency of breast tumors on digitalized slides" (French Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,755,840, issued on Oct. 6, was assigned to Institut Curie (Paris), Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris) and Ecole Nationale Superieure des Mines de Paris (Paris).

"Prediction of BRCAness/homologous recombination deficiency of breast tumors on digitalized slides" was invented by Anne Vincent Salomon (Paris), Thomas Walter (Paris), Etienne Decenciere (Avon, France), Tristan Lazard (Paris) and Guillaume Bataillon (Toulouse, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a computer-implemented method for identifying at least one class of at least one biological image, notably to ...